Impact of fecal microbiota transplantation on lung function and gut microbiome in an ARDS rat model: A multi-omics analysis including 16S rRNA sequencing, metabolomics, and transcriptomics
International Journal of Immunopathology and Pharmacology · 2025
DOI: 10.1177/03946320251333982 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2025. Verfasst von Dongwei Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Respiratory Distress Syndrome, Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Liuzhou Science and Technology Plan Project, Natural Science Foundation of Sichuan Province of China, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Objective
Acute respiratory distress syndrome (ARDS) is a severe pulmonary condition characterized by inflammation and lung damage, frequently resulting in poor clinical outcomes. Recent studies suggest that the gut-lung axis, mediated by gut microbiota, is critical in ARDS progression. This study investigates the therapeutic potential of fecal microbiota transplantation (FMT) in an ARDS rat model ( n = 6).
Introduction
The pathogenesis of ARDS involves complex interactions between the lungs and gut, with microbiota playing a key role. Understanding the effects of FMT on lung function and gut microbiota may provide new therapeutic strategies for ARDS management.
Methods
Sprague-Dawley rats were pre-treated with a broad-spectrum antibiotic cocktail to create a germ-free state and subsequently exposed to intranasal lipopolysaccharide to induce ARDS. The rats then received FMT treatment. Lung samples were analyzed using histopathology and transcriptomics. Fecal samples were analyzed using 16S rRNA sequencing and metabolomics.
Results
FMT treatment significantly reduced lung injury and improved pulmonary function, as evidenced by increased partial pressure of arterial oxygen (PaO 2 ) and decreased partial pressure of arterial carbon dioxide (PaCO 2 ). FMT also significantly altered in gut microbiota composition by regulating the gut microbiota composition of Akkermansia and Lactobacillus , restoring the abundance of genera such as Muribaculaceae , Clostridia_UCG-014 , Prevotella , and Adlercreutzia , while reducing Romboutsia . FMT restored key metabolic pathways involved in lipid metabolism, amino acid biosynthesis, and immune regulation, including the modulation of immune pathways like mTOR signaling. These alterations contribute to reduced lung injury and improved pulmonary function.
Conclusion
These findings indicate that FMT may exert its beneficial effects in ARDS by modulating the gut microbiota and enhancing metabolic and immune responses. However, given that this study remains in the preclinical stage, further validation in clinical studies is necessary before considering clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- Department of Respiratory and Critical Care Medicine, Liuzhou People's Hospital, Guangxi Medical University, Liuzhou, Guangxi, China.
- Key Laboratory of Diagnosis, Treatment and Research of Asthma and Chronic Obstructive Pulmonary Disease, Liuzhou, Guangxi, China.
- Department of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, China.
ORCID-Profile: Xianming Fan
Förderung
- Liuzhou Science and Technology Plan Project
- Natural Science Foundation of Sichuan Province of China
- Sichuan Science and Technology Program
- Self-funded Research Project of Guangxi Autonomous Region
Zitieren
APA
Zhang, D., Zhang, Z., Liao, L., Dong, B., Xiong, X., Qin, X., & Fan, X. (2025). Impact of fecal microbiota transplantation on lung function and gut microbiome in an ARDS rat model: A multi-omics analysis including 16S rRNA sequencing, metabolomics, and transcriptomics. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320251333982
Vancouver
Zhang D, Zhang Z, Liao L, Dong B, Xiong X, Qin X, et al. Impact of fecal microbiota transplantation on lung function and gut microbiome in an ARDS rat model: A multi-omics analysis including 16S rRNA sequencing, metabolomics, and transcriptomics. International Journal of Immunopathology and Pharmacology. 2025. doi:10.1177/03946320251333982
BibTeX
@article{Zhang2025,
author = {Zhang, Dongwei and Zhang, Zhenqiang and Liao, Longxiong and Dong, Biying and Xiong, Xia and Qin, Xuejun and Fan, Xianming},
title = {Impact of fecal microbiota transplantation on lung function and gut microbiome in an ARDS rat model: A multi-omics analysis including 16S rRNA sequencing, metabolomics, and transcriptomics},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2025},
doi = {10.1177/03946320251333982}
}
EUVIMED